Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Other Assets
Tibet Rhodiola Pharmaceutical Holding Co
Other Assets Peer Comparison
Competitive Other Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Other Assets
¥8.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Assets
¥11.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
12%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Assets
¥759.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
43%
|
CAGR 10-Years
29%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Assets
¥203.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
59%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Assets
¥2.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
12%
|
CAGR 10-Years
71%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Other Assets?
Other Assets
8.9m
CNY
Based on the financial report for Mar 31, 2024, Tibet Rhodiola Pharmaceutical Holding Co's Other Assets amounts to 8.9m CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Other Assets growth rate?
Other Assets CAGR 10Y
0%
Over the last year, the Other Assets growth was 0%.